Line 23
  • ~90%

    reduction in reporting effort

  • ~3 month

    structured reporting cycle

  • ~50 policies

    enforced enterprise-wide

Client Intro

A premier U.S. federal biomedical research agency operates a large-scale enterprise platform supporting research reporting, compliance, and public transparency across approximately 1,200 principal investigators and multiple institutes. As reporting requirements expanded and system complexity increased, the agency needed a more scalable, full-stack IT solution to ensure data accuracy, enforce policy compliance, and support evolving mandates  without disrupting ongoing research operations.

Path 1688

Challenge

Before platform digitization, annual research reporting across institutes was entirely manual — taking up to six months per cycle, requiring dedicated staff at each institute, and offering no cross-program visibility or compliance tracking.

As congressional mandates evolved and reporting complexity grew, the agency needed a centralized platform to consolidate fragmented processes, enforce compliance enterprise-wide, and enable longitudinal data visibility — without disrupting ongoing research operations.

Originally developed in the early 2000s, the platform continues to evolve to keep pace with the growing complexity of scientific and legislative demands.

Solution

Originally established in the early 2000s, the platform was designed with a vertically integrated, full-stack architecture. Since 2016, DMI has supported and continues to advance the platform across infrastructure, application development, security, and user support — enabling continuous adaptation to evolving requirements. This model enables end-to-end ownership, eliminating handoffs and accelerating delivery.

Built on a secure, high-performance architecture leveraging Oracle and TeraScript, the platform supports rapid development and deployment of new capabilities. API-driven integrations using Node.js improved connectivity with external research systems and enhanced data exchange across the ecosystem.

This approach enables real-time implementation of new mandates, even during active reporting cycles, while maintaining system stability. Emerging AI capabilities are also being introduced to improve accessibility, transparency, and insight generation across research data.

Line 23

Technologies and Capabilities

Group 2907

Platform & Development

Group 2907

Infrastructure & Security

Group 2907

Data & Integration

Group 2907

Innovation Enablement

Impact

By replacing fragmented, manual reporting with a centralized, continuously evolving platform, the agency achieved a fundamental shift in research oversight and compliance.

Reporting cycles were reduced from six months to three, significantly improving efficiency and reducing operational overhead. Data consistency and compliance enforcement improved across institutes, supported by centralized processes and automation.

The platform also introduced long-term visibility into research activity, enabling tracking and analysis across decades of data.

Today, the system provides a scalable foundation for continuous innovation — allowing the agency to respond faster to new mandates while improving transparency, compliance, and decision-making across the research ecosystem. Despite operating with a lean team, the platform delivers enterprise-scale outcomes — frequently recognized internally for doing more with significantly fewer resources.
 

Path 1381
DoMore Logo Reverse 1

About DMI

DMI is a leading global provider of digital services working at the intersection of public and private sectors. With broad capabilities across IT managed services, cybersecurity, cloud migration and application development, DMI provides onsite and remote support to clients within governments, healthcare, financial services, transportation, manufacturing, and other critical infrastructure sectors. DMI’s commitment to excellence in service delivery has resulted in dramatic growth, with clients among all fifteen U.S. Federal Departments and hundreds of Fortune 1000 companies.